GGrantIndex
Sort

64,565 grants matching drug discovery

Expeditions: Collaborative Research: Understanding the World Through Code

$807,655
Osbert Bastani · University Of Pennsylvania · · FY2020 · CSE

PRECLINICAL MEDICATIONS DISCOVERY & ABUSE LIABILITY TESTING FOR NIDA

$807,609
Louis S. Harris · Virginia Commonwealth University · N01 · FY2015 · DA

Bioanalysis, Drug Metabolism and New Drug Discovery

$807,595
Josephine Earley · National Institute On Aging · ZIA · FY2017 · AG

Improving Kidney Function Assessment in Health and Disease

$807,560
Lesley Ann Inker · Tufts Medical Center · R01 · FY2021 · DK

A Vector-free Intracellular Delivery Platform for Drug Discovery

$807,544
Jonathan Brian Gilbert · Sqz Biotechnologies Company, Inc. · R44 · FY2017 · GM

Structural definition of CD4-induced HIV-1 Env conformational changes required for infection

$807,497
Priyamvada Acharya · Duke University · R01 · FY2025 · AI

Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV

$807,482
John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK

JAK1/2 as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target

$807,480
David C Fajgenbaum · University Of Pennsylvania · R01 · FY2023 · HL

Discovery and/or Validation of Pharmacodynamic Markers

$807,274
Jeffrey Aube · Univ Of North Carolina Chapel Hill · U19 · FY2024 · NS

Identifying and validating new antibiotic targets in cell wall synthesis pathways

$807,102
Thomas G Bernhardt · Harvard Medical School · R01 · FY2013 · AI

Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels

$807,060
Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI

Modeling hyperactivity in neurological disease using patient-derived pluripotent stem cells

$807,040
Fred H Gage · Johns Hopkins University · U19 · FY2016 · MH

Plasminogen activator inhibitor 1 (PAI1) as a therapeutic target for maternal endothelial dysfunction in preeclampsia

$806,978
Molly E McAdow · Yale University · R01 · FY2025 · HL

IDENTIFYING ALS THERAPEUTICS THROUGH MULTIPLEXED DRUG DISCOVERY TECHNOLOGIES

$806,972
The Trustees Of Columbia University In The City Of New York · · FY2020 · Defense Health Agency

Polymerase Inhibitors of Respiratory Syncytial Virus

$806,958
Richard K. Plemper · Georgia State University · R01 · FY2020 · AI

New epigenetic inhibitors for Alzheimer's disease treatment

$806,956
Changning Wang · Massachusetts General Hospital · R01 · FY2024 · AG

Mapping gut-spinal cord connections in visceral pain

$806,943
David J Julius · University Of California, San Francisco · U01 · FY2019 · NS

Development of Novel Melanocortin-4 Receptor Peptide Agonists for the Treatment ofMC4R Haploinsufficiency

$806,879
Tomi K Sawyer · Courage Therapeutics, Inc. · R42 · FY2022 · DK

Mechanisms of Beta Cell Failure

$806,845
Domenico Accili · Columbia University Health Sciences · R01 · FY2023 · DK

Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction

$806,792
L. Elliot Hong · University Of Maryland Baltimore · P50 · FY2019 · MH

A SCALABLE SCREENING PLATFORM TO ACCELERATE EARLY DRUG DISCOVERY FOR DIVERSE ALS SUBTYPES

$806,741
Regents Of The University Of California, San Francisco, The · · FY2021 · Defense Health Agency

Discovery of Natural Product based Drugs and Bioenergetic Materials from CR

$806,645
David H Sherman · University Of Michigan At Ann Arbor · U01 · FY2013 · TW

Computational Infrastructure for Automated Force Field Development and Optimization

$806,572
Madushanka Manathunga · Attmos Inc. · R44 · FY2025 · GM

Pharmacogenomics of HIV Therapy

$806,550
David W Haas · Vanderbilt University Medical Center · R01 · FY2025 · AI

Identification and Characterization of Senescent Cells in Molecular Subtypes of Alzheimer's Disease

$806,379
Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG